Category

Cohort News

Prevencio Receives FDA Breakthrough Device Designation for HART CADhs, Its Artificial Intelligence-driven Blood Test for Obstructive Coronary Artery Disease

//
Categories
KIRKLAND, Wash.–(BUSINESS WIRE)–Prevencio, Inc., the leader in artificial intelligence-powered blood tests for cardiovascular diagnostics, announces that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to its HART CADhs® test. This designation recognizes HART CADhs as an...
Read More →

AccurKardia’s AccurECG Named “Best New Technology Solution for ECG” in 9th Annual MedTech Breakthrough Awards Program

//
Categories
Prestigious International Annual Awards Program Recognizes Standout Digital Health & Medical Technology Products and Companies NEW YORK–(BUSINESS WIRE)–AccurKardia, an innovator in ECG-based diagnostics technology, today announced that its AccurECGTM software platform has been selected as winner of the “Best New...
Read More →

Conavi Medical’s Novasight Hybrid™ System Named “Product Innovation of the Year” at 2025 Minnesota Manufacturing Awards

//
Categories
Award recognizes Novasight Hybrid™ System’s significant advance in intracoronary imaging technology TORONTO, May 08, 2025 (GLOBE NEWSWIRE) — Conavi Medical Corp. (TSXV: CNVI; OTCQB: CNVIF) (“Conavi Medical” or the “Company”), a medical device company focused on designing, manufacturing, and marketing...
Read More →

INBRAIN Neuroelectronics Awarded €4 Million Grant from Spain’s PERTE Chip Program to Advance Graphene-Based Brain-Computer Interfaces

//
Categories
BARCELONA, Spain–(BUSINESS WIRE)–INBRAIN Neuroelectronics, a clinical-stage neurotechnology company developing precision brain-computer interfaces (BCIs) powered by graphene, announced today it has been awarded a €4 million grant by the Spanish Ministry of Industry and Tourism through the PERTE Chip initiative. The...
Read More →